Law Firm Investigates Former Drug Maker Over Crypto Pivot
New York, Tuesday, 4 August 2026.
Abbott Cooper PLLC launched a fiduciary duty investigation into Stablecoin Development Corporation following its shift from pharmaceuticals to crypto, which triggered a $53.8 million operating loss.
Legal Scrutiny Over Strategic Pivot
Stockholder rights law firm Abbott Cooper PLLC has initiated a formal investigation into Stablecoin Development Corporation (NYSE American: SDEV), formerly known as NovaBay Pharmaceuticals, Inc. [1]. The probe focuses on potential breaches of fiduciary duty by the board of directors regarding corporate decisions made following the company’s strategic pivot to digital asset development [1]. Specifically, the investigation scrutinizes actions impacting long-term shareholders who held positions prior to August 19, 2025 [1]. The announcement was released on August 3, 2026, marking a significant legal challenge for the company as it navigates its new identity in the cryptocurrency sector [1].
Abbott Cooper PLLC is investigating claims on a contingency fee basis, meaning there is no cost to stockholders unless a recovery is obtained [1]. Shareholders who have continuously held shares since before the specified cutoff date are encouraged to contact the firm to discuss their legal rights [1]. This legal action comes amidst a broader period of transformation for the company, which has shifted its core business model from pharmaceuticals to blockchain-based financial instruments [4]. The timing of the investigation coincides with the release of second-quarter financial results that highlight the volatility inherent in the company’s new asset class [3].
Financial Performance and Asset Volatility
On July 31, 2026, Stablecoin Development Corp reported its second-quarter 2026 results, revealing a stark contrast between operational revenue and asset valuation losses [3]. The company generated $2.2 million in staking revenue from the Sky Protocol’s SKY token, which roughly matched its cash operating expenses for the period [5]. However, the company recorded a $53.8 million operating loss, driven largely by a $50.6 million unrealized loss on digital assets due to declining SKY token prices [3]. This unrealized loss constitutes approximately 94.052 percent of the total operating loss, underscoring the heavy exposure to cryptocurrency market fluctuations [5].
For the first half of 2026, SDEV reported $4.7 million in staking revenue and a $31.6 million operating loss, confirming that valuation-driven losses did not impact cash position or operations [3]. As of June 30, 2026, the company held 2.29 billion SKY tokens, and by July 27, 2026, holdings increased to approximately 2.30 billion tokens, representing roughly 10% of the total SKY supply [3]. Despite the staking rewards earning 31.7 million SKY during Q2 2026, technical sentiment for SDEV was categorized as a Strong Sell with an average trading volume of 789,987 as of the article date [3]. The concentration of assets remains a key risk factor, with about 94% of assets tied to SKY [5].
Corporate Relocation and Rebranding Efforts
In a move to reduce corporate costs, Stablecoin Development Corporation relocated its corporate headquarters from California to West Palm Beach, Florida [4]. The new headquarters is located at Suite 800 at the Esperanté Corporate Center, 222 Lakeview Ave., West Palm Beach, FL, as disclosed in Q2 2026 financial filings [4]. This relocation aligns with the company’s rebranding from NovaBay Pharmaceuticals in March 2026 to focus entirely on cryptocurrency [4]. The shift represents a complete departure from its previous pharmaceutical operations, aiming to establish the firm as an on-chain holding company within the Sky Protocol ecosystem [3].
The company also eliminated all remaining warrant liabilities via cashless exercises during Q2 2026, though filings highlighted potential share dilution tied to prefunded warrants [4][5]. One tranche of warrants permits exercise for up to about 33.5 million shares, creating a potential dilution threat alongside the valuation overhangs [5]. While the company maintains a Neutral rating from TipRanks’ AI Analyst due to weak operating performance, the strategic relocation and asset consolidation suggest a long-term commitment to the digital asset space despite current market headwinds [3]. Investors are monitoring whether the cost-saving measures from the relocation will offset the volatility seen in the digital asset portfolio [2].